Nasdaq’s QBTC Bitcoin Options Delayed as CME Challenges SEC Approval
- The U.S Securities and Exchange Commission, SEC, has paused Nasdaq’s QBTC bitcoin options after a challenge from CME Group.
- CME says bitcoin options should fall under the CFTC because bitcoin is a commodity.
- The exchange commission will review public comments through Aug. 24 to decide whether to keep or change its approval.
Nasdaq’s plan to list bitcoin index options is still on hold, and the reason has nothing to do with bitcoin’s price. It comes down to which regulator gets to decide.
Why Nasdaq and CME Are Fighting Over Bitcoin Options
The SEC granted Nasdaq PHLX conditional approval in May to list QBTC, cash-settled options built on the Nasdaq Bitcoin Index, itself defined as the CME CF Bitcoin Real-Time Index divided by 100. That detail matters. Nasdaq built its product on a benchmark CME owns and already uses for its own regulated bitcoin futures and options, which trade under CFTC oversight.
Nasdaq PHLX first filed the QBTC proposal back in September, then amended it in May. The SEC’s Division of Trading and Markets granted conditional approval through an accelerated review process on May 22, with the options designed as European-style contracts settling in U.S. dollars rather than bitcoin itself.
CME filed its jurisdictional challenge in June. Its position is straightforward: bitcoin is a commodity, not a security, so any option tied directly to its value is a commodity option swap that falls exclusively under the CFTC, not the SEC. The SEC agreed to review the dispute and paused its own approval while it does, with the order made public on July 31.
This is different from a dispute over whether the product should exist. It’s about which of two federal agencies gets to regulate it, and the answer could reach beyond this one contract.
What It Means for the Market
For now, the practical effect is delay. Nasdaq cannot launch QBTC while the stay is in place, and even the original approval required separate CFTC exemptions before trading could begin, so the product was never a single signature away from going live. The comment window closes August 24, and the SEC has not set a deadline for a final ruling after that.
Two outcomes are on the table. The SEC could uphold its own approval and let QBTC proceed largely as designed, keeping the product under its oversight. It also could side with CME, which would likely force Nasdaq to either register the contract with the CFTC under an entirely different framework or redesign it as options on a bitcoin spot ETF instead, both of which would push the launch back further.
The bigger stake is precedent. If the SEC sides with CME, that could push future bitcoin-linked options products toward the CFTC by default, reshaping which exchanges can list them and under what rules.
If the SEC holds its ground instead, CME’s benchmark would remain open to competing products built on top of it. Either outcome affects how new bitcoin derivatives reach the market long after this specific contract is resolved.
Source:
